• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MLH1-93G>A 多态性对 MLH1/EPM2AIP1 启动子活性的功能影响。

Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity.

机构信息

Department of Laboratory Medicine and Pathobiology, University of Toronto, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 1 King's College Circle, Toronto, ON, Canada.

出版信息

Oncol Rep. 2011 Mar;25(3):809-15. doi: 10.3892/or.2010.1129. Epub 2010 Dec 30.

DOI:10.3892/or.2010.1129
PMID:21206982
Abstract

Defective mismatch repair leads to the microsatellite instability (MSI) phenotype of colorectal cancer (CRC). We previously showed that the MLH1-93G>A promoter polymorphism is strongly associated with MSI tumours, suggesting a modifier role for this polymorphism in CRC. The MLH1 promoter is bi-directional with the EPM2AIP1 gene located on the antisense strand. In order to evaluate the functional effects of this polymorphism, we transfected a panel of CRC, endometrial cancer and non-tumourigenic cell lines with MLH1 luciferase promoter constructs. We used constructs in reverse orientation to assess the effect of this polymorphism on EPM2AIP1. The luciferase activities were compared using a two-sided Student's t-test. Electrophoretic mobility shift assays (EMSAs) were used to evaluate whether differential protein binding was responsible for the differences in promoter activity. We observed a higher level of activity with the -93G allele in all the cell lines observed; including the CRC cell line, HCT116 (P=0.002), the endometrial cancer cell line, HEC-1-A (P<0.001) and the normal colonic cell line, CCD-841-CoTr (P=0.002). This polymorphism also affected EPM2AIP1 transcription with the -93A allele demonstrating higher promoter activity in the HCT116 (P=0.007) and HEC-1-A (P=0.004) cells. The EMSA results suggest that this polymorphism alters the affinity of nuclear factors that bind to this region. Our findings indicate that the -93G>A polymorphism modifies the efficiency of MLH1/EPM2AIP1 transcription.

摘要

错配修复缺陷导致结直肠癌(CRC)的微卫星不稳定(MSI)表型。我们之前表明,MLH1-93G>A 启动子多态性与 MSI 肿瘤强烈相关,提示该多态性在 CRC 中具有修饰作用。MLH1 启动子是双向的,EPM2AIP1 基因位于反义链上。为了评估该多态性的功能影响,我们用 MLH1 荧光素酶启动子构建体转染了一系列 CRC、子宫内膜癌和非肿瘤细胞系。我们使用反向方向的构建体来评估该多态性对 EPM2AIP1 的影响。使用双侧学生 t 检验比较荧光素酶活性。电泳迁移率变动分析(EMSA)用于评估差异蛋白结合是否是导致启动子活性差异的原因。我们观察到所有观察到的细胞系中,-93G 等位基因的活性水平更高;包括 CRC 细胞系 HCT116(P=0.002)、子宫内膜癌细胞系 HEC-1-A(P<0.001)和正常结肠细胞系 CCD-841-CoTr(P=0.002)。该多态性也影响 EPM2AIP1 的转录,-93A 等位基因在 HCT116(P=0.007)和 HEC-1-A(P=0.004)细胞中表现出更高的启动子活性。EMSA 结果表明,该多态性改变了与该区域结合的核因子的亲和力。我们的研究结果表明,-93G>A 多态性改变了 MLH1/EPM2AIP1 转录的效率。

相似文献

1
Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity.MLH1-93G>A 多态性对 MLH1/EPM2AIP1 启动子活性的功能影响。
Oncol Rep. 2011 Mar;25(3):809-15. doi: 10.3892/or.2010.1129. Epub 2010 Dec 30.
2
Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.由MLH1 - 93G/A多态性定义的单倍型与散发性结直肠癌中的MLH1启动子高甲基化相关。
BMC Res Notes. 2014 Nov 24;7:835. doi: 10.1186/1756-0500-7-835.
3
MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.MLH1基因-93G>A启动子多态性与微卫星不稳定型结直肠癌风险
J Natl Cancer Inst. 2007 Mar 21;99(6):463-74. doi: 10.1093/jnci/djk095.
4
The MLH1 -93 promoter variant influences gene expression.MLH1-93 启动子变异影响基因表达。
Cancer Epidemiol. 2010 Feb;34(1):93-5. doi: 10.1016/j.canep.2009.12.009. Epub 2010 Jan 8.
5
MLH1-93G > A is a risk factor for MSI colorectal cancer.MLH1-93G > A 是 MSI 结直肠癌的风险因素。
Carcinogenesis. 2011 Aug;32(8):1157-61. doi: 10.1093/carcin/bgr089. Epub 2011 May 11.
6
Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.MLH1-93G>A 多态性与结直肠癌风险的关联。
PLoS One. 2012;7(11):e50449. doi: 10.1371/journal.pone.0050449. Epub 2012 Nov 30.
7
MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer.MLH1基因启动子-93G>A多态性与错配修复缺陷型结直肠癌风险
Int J Cancer. 2008 Nov 15;123(10):2456-9. doi: 10.1002/ijc.23770.
8
EPM2AIP1 immunohistochemistry is inadequate as a surrogate marker for MLH1 promoter hypermethylation testing in colorectal cancer.EPM2AIP1 免疫组化不能作为结直肠癌 MLH1 启动子甲基化检测的替代标志物。
Hum Pathol. 2024 Aug;150:74-77. doi: 10.1016/j.humpath.2024.06.017. Epub 2024 Jun 28.
9
Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.关于:MLH1基因93G>A启动子多态性与微卫星不稳定型结直肠癌风险
J Natl Cancer Inst. 2007 Oct 3;99(19):1490; author reply 1490-1. doi: 10.1093/jnci/djm137. Epub 2007 Sep 25.
10
Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer.家族性和散发性结直肠癌中-93 MLH1 启动子多态性的发生率。
Colorectal Dis. 2013 Mar;15(3):e118-23. doi: 10.1111/codi.12112.

引用本文的文献

1
Genetic Variability in Cisplatin Metabolism in Kidney Injury in Patients With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiotherapy.接受根治性放化疗的头颈部鳞状细胞癌患者肾损伤中顺铂代谢的基因变异性
Head Neck. 2025 Oct;47(10):2683-2692. doi: 10.1002/hed.28179. Epub 2025 May 8.
2
Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.顺铂代谢途径中的遗传变异与局部晚期头颈部鳞状细胞癌患者的结局。
Sci Rep. 2023 Oct 5;13(1):16762. doi: 10.1038/s41598-023-44040-7.
3
Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study.
头颈部鳞状细胞癌中临床特征和基因变异与顺铂诱导的耳毒性严重程度的关联:一项前瞻性队列研究
Cancers (Basel). 2023 Mar 14;15(6):1759. doi: 10.3390/cancers15061759.
4
DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers.散发性实体瘤中的 DNA 错配修复基因变异。
Int J Mol Sci. 2020 Aug 3;21(15):5561. doi: 10.3390/ijms21155561.
5
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.DNA 修复与结直肠癌:遗传易感性中的新角色。
Int J Cancer. 2020 Jan 15;146(2):363-372. doi: 10.1002/ijc.32516. Epub 2019 Jul 4.
6
Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy.错配修复通路基因多态性可预测接受辅助同步放化疗的口腔鳞状细胞癌患者的临床结局。
Cancers (Basel). 2019 Apr 29;11(5):598. doi: 10.3390/cancers11050598.
7
Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer.根据结直肠癌中雌激素受体β状态的全基因组 DNA 甲基化差异。
Epigenetics. 2019 May;14(5):477-493. doi: 10.1080/15592294.2019.1595998. Epub 2019 Mar 30.
8
Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients.DNA错配修复通路基因多态性可预测头颈部鳞状细胞癌患者对顺铂同步放化疗的毒性反应及疗效。
Oncotarget. 2018 Jul 3;9(51):29538-29547. doi: 10.18632/oncotarget.25268.
9
MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF mutation.MLH1-93G/a 多态性与 BRAF 突变的发育不良无蒂锯齿状腺瘤中 MLH1 启动子甲基化和蛋白缺失相关。
BMC Cancer. 2018 Jan 5;18(1):35. doi: 10.1186/s12885-017-3946-5.
10
Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.结直肠癌中多态性rs1800734对MLH1基因启动子区及其侧翼区域转录因子结合和表观遗传调控的影响
Epigenetics. 2017 Jun 3;12(6):441-448. doi: 10.1080/15592294.2017.1305527. Epub 2017 Mar 17.